Karyomapping in preimplantation genetic testing for β-thalassemia combined with HLA matching: a systematic summary
Karyomapping in preimplantation genetic testing for β-thalassemia combined with HLA matching: a systematic summary
复制标题
β地中海贫血植入前基因检测中的核型定位与 HLA 匹配相结合:系统总结
DOI:
10.1007/s10815-019-01595-7
复制
发表时间:
2019-11-22
影响因子:
3.1
通讯作者:
Xu,Yan-Wen
中科院分区:
文献类型:
--
作者:
Wang,Jing;Lu,Bao-Min;Xu,Yan-Wen
PurposeTo investigate the validity, accuracy, and clinical outcomes of Karyomapping in preimplantation genetic testing (PGT) for β-thalassemia combined with human leukocyte antigen (HLA) matching.MethodsA total of 128 cycles from January 2014 to December 2017 were identified, and 1205 embryos were biopsied. The case group included 88 cycles using Karyomapping for PGT-HLA, compared with 40 cycles using polymerase chain reaction-short tandem repeat (PCR-STR) as the control group.ResultsThere were significant differences in the HLA matching rate (21.34vs.14.37%), the matched transferable embryo rate (9.79vs.14.07%), the clinical pregnancy rate (65.08vs.41.86%), and the spontaneous miscarriage rate (2.44vs.22.22%) between the case and control groups. In the case group, nearly 1/3 (33.37%) of the embryos showed aneuploidy. According to the results of single nucleotide polymorphism (SNP) haplotype analysis, the recombination rates ofHBB(hemoglobin subunit beta) andHLAwere 11.46% and 5.61% respectively.HLAgene recombination was mostly distributed between HLA-A and HLA-B and the downstream region of HLA-DQB1. In addition, STR analysis could be considered in the case of copy-neutral loss of heterozygosity (LOH) in the region where theHLAgene is located.ConclusionKaryomapping contributes to accurate selection of matched embryos, along with aneuploidy screening. However, STRs assist identification in cases of LOH in the target region.